[(-)- -Bisabolol and cis-2-(hexadiin-(2,4)-ylidene)-1,6-dioxaspiro-(4,4)-nonene-(3) in commercial extracts of camomile].
D000438:Alcohols / Q000032:analysis; D000893:Anti-Inflammatory Agents / Q000032:analysis; D002849:Chromatography, Gas; D003510:Cyclohexanes / Q000032:analysis; D004987:Ethers / Q000032:analysis; D008722:Methods; D010276:Parasympatholytics / Q000032:analysis; D010936:Plant Extracts / Q000032:analysis / Q000592:standards; D010946:Plants, Medicinal / Q000032:analysis*; D013141:Spiro Compounds / Q000032:analysis* / Q000302:isolation & purification; D013729:Terpenes / Q000032:analysis*
D000438:Alcohols; D000893:Anti-Inflammatory Agents; D003510:Cyclohexanes; D004987:Ethers; D010276:Parasympatholytics; D010936:Plant Extracts; D013141:Spiro Compounds; D013729:Terpenes
(-)- -Bisabilol und cis-2-(Hexadiin-(2,4)-yliden)-1,6-dioxaspiro-(4,4)-nonen-(3) in handelsüblichen Kamillen-Extrakten.